Having uncovered the NAD+-degrading and profibrotic role of CD38 in obstructive nephropathy, we then asked whether NAD+ supplementation can confer protective effects against obstruction-induced renal fibrosis. The gene discussed is CD38; the disease is renal fibrosis.